Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure

European Journal of Clinical Investigation

Volumn 35, Issue 1, 2005, Pages 24-31

  Berger, Rudolf ^a,b   Huelsmann, M ^a   Strecker, K ^a   Moertl, D ^a   Moser, P ^a   Bojic, A ^a   Pacher R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Death; Heart failure; Natriuretic peptides; Prognosis; Pump failure; Sudden

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN; NEUROHORMONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DISEASE COURSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SUDDEN DEATH;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; DEATH, SUDDEN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROTEIN PRECURSORS; RISK ASSESSMENT; ROC CURVE; SURVIVAL RATE;

EID: 13244271893     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01442.x     Document Type: Article

References (22)

1. Troughton RW, Frampton MC, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.
2. Rodeheffer RJ, Naftel DC, Stevenson LW, Porter CB, Young JB, Miller LW et al. Secular trends in cardiac transplant recipient and donor management in the United States 1990-94. A multi-institutional study. Cardiac Transplant Residential Database Group. Circulation 1996;94:2883-9.
3. Stevenson LW, Warner SL, Steimle AE, Fonarow GC, Hamilton MA, Moriguchi JD et al. The impending crisis awaiting cardiac transplantation: modeling a solution based on selection. Circulation 1994;89:450-7.
4. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al. for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
5. Berger R, Huelsmann M, Strecker K, Bojic A, Moser P, Staneck B et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7.
6. Stevenson WG, Stevenson LW. Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol 2001;12:112-4.
7. Costantini O, Drabek C, Rosenbaum DS. Can sudden cardiac death be predicted from the T wave of the ECG? A critical examination of T wave alternans and QT interval dispersion. Pacing Clin Electrophysiol 2000;23:1407-15.
8. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-16.
9. Omland T, Bonarjee VV, Nilsen DW, Sundsfjord JA, Lie RT, Thibault G et al. Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. Br Heart J 1993;70:409-14.
10. Hall C, Rouleau JL, Moye L, de Champlain J, Bichet D, Klein M et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994;89:1934-42.
11. Stanek B, Frey B, Hulsmann M, Berger R, Sturm B, Strametz-Juranek J et al. Prognostic evaluation of neurohumoral plasma levels before and during β-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol; 2001;38:436-42.
12. Selvais PL, Robert A, Ahn S, van Linden F, Katelslegers JM, Pouleur H et al. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 2000;6:201-7b.
13. Hulsmann M, Berger R, Sturm B, Bojic A, Woloszczuk W, Bergler-Klein J et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J 2002.
14. Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633-41.
15. Hulsmann M, Stanek B, Frey B, Sturm B, Putz D, Kos T et al. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol 1998;32:1695-700.
16. Kim SG, Fogoros RN, Furman S, Connolly SJ, Kuck KH, Moss AJ. Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophyiology Policy Conference, February 9-10 1993. PACE 1993;16:1358-62.
17. Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 2000;35:1256-62.
18. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9.
19. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
20. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford J, Morrison CE et al. Biochemical detection of left ventricular dysfunction. Lancet 1998;351:9-13.
21. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
22. Task Force for the Diagnosis and Treatment of Chronic Heart Failure European Society of Cardiology. W. J. Remme and K. Swedberg (Co-Chairmen). Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.